Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study

Allergologia et Immunopathologia

Volumn 29, Issue 6, 2001, Pages 238-244

  Ariano, R ^a   Spadolini, I ^b   Panzani, R C ^c  

^a ASL n 1 Imperiese Ospedale S Charles di Bordighera   (Italy)

^b Anallegro srl Firenze   (Italy)

^c Laboratoire de Recherches   (France)

Author keywords

Cupressus arizonica; Cupressus sempervirens; Placebo controlled study; Specific sublingual immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CUPRESSUS ARIZONICA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; RESPIRATORY TRACT ALLERGY; SCORING SYSTEM; SKIN TEST; TREATMENT OUTCOME;

EID: 0035663289     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0546(01)79065-9     Document Type: Article

References (38)

1. L'allergie respiratoire aux pollens de Conifères
2. Increase of respiratory allergy to the pollens of cypresses in the South of France
3. Allergenic significance of Cupressaceae pollens in some parts of the Mediterranean area
4. Allergia respiratoria al polline di Cupressaceae. Folia allergol
5. Pollinosis in a Mediterranean area (Riviera Ligure, Italy): Ten years of pollen counts, correlation with clinical sensitization and metereological data
6. Airbone Cupressaceae pollen in Southern Italy
7. Allergens of Arizona cypress (Cupressus arizonica) pollen: Characterization of the pollen extract and identification of the allergenic components
8. Sensivity to Cupressus: Allergenic significance in Cordoba (Spain)
9. Cupressaceae pollinosis in the Madrid area
10. Double blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratoty allergy to Cupressus sempervirens
11. An epidemiological survey on the allergological importance of some emerging pollens in Italy
12. Repository emulsion therapy for mountain cedar pollinosis: A double blind study
13. Immunotherapy for mountain cedar pollinosis. A double blind study
14. Suppression of the late cutaneous response by immunotherapy
15. The relationship between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis
16. Clinical èffects of immunotherapy on japanese cedar pòllinosis in the season of cedar and cypress pollination
17. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children
18. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: A double-blind, placebo-controlled study
19. A double blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract
20. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: A double-blind study
21. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietariajudaica pollen. A double-blind study
22. Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
23. Sublingual immunotherapy with a standardised grass pollen extract: A double-blind placebo-controlled study
24. Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis
25. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house - dust mites: A double-blind, placebo controlled study
26. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: A double blind, placebo-controlled study
27. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study
28. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study
29. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis
30. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial
31. Efficacy of sublingual route of immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study
32. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization
33. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis
34. Sublingual immunotherapy: A double-blind, placebo controlled trial with Parietaria judaica extract standardized with rhinoconjunctivitis, asthma, or both
35. Diagnosis of allergy by an in vitro test for the allergen antibodies
36. Rhinomanometry and nasal peak respiratory and inspiratory flow rate
37. Pollen capture media: A comparative study